Risk stratification in patients undergoing interventional left atrial appendage occlusion-Prognostic impact of

Michael Gotzmann1, Dinah S Choudhury2, Maximilian Hogeweg1

  • 1Cardiovascular Center, St. Josef Hospital Bochum, Ruhr-University, Bochum, Germany.

Clinical Cardiology
|January 23, 2020
PubMed

Insights

Interventional left atrial appendage (LAA) closure is an option for stroke prevention. Logistic EuroSCORE II greater than 2% independently predicts mortality in these patients, aiding risk stratification.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Interventional left atrial appendage (LAA) closure offers an alternative to oral anticoagulation for stroke prophylaxis, especially in patients with high bleeding risk due to comorbidities.
  • The clinical benefit of LAA occlusion in multimorbid patients with reduced prognosis remains a concern.

Purpose of the Study:

  • To identify independent preprocedural risk factors for improved risk stratification in patients undergoing interventional LAA occlusion.
  • To evaluate the prognostic value of logistic EuroSCORE II and the impact of end-stage renal disease on outcomes.

Main Methods:

  • A consecutive series of 128 patients undergoing interventional LAA occlusion with the Amplatzer device were studied.
  • Preprocedural risk assessment utilized the logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) II.
  • Primary endpoint was all-cause mortality; secondary endpoints included thromboembolic events and severe bleeding.

Main Results:

  • During a mean follow-up of 781 days, 27% of patients died.
  • Logistic EuroSCORE II > 2% was the sole independent predictor of mid-term mortality (HR 4.55, P=.005).
  • End-stage renal disease (26% of patients) did not significantly impact mortality, thromboembolic events, or bleeding.

Conclusions:

  • Preprocedural logistic EuroSCORE II assessment provides independent prognostic information in patients undergoing interventional LAA occlusion.
  • Logistic EuroSCORE II can enhance risk stratification for these highly selected patients.
  • End-stage renal failure was not associated with significantly worse outcomes in this cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
159
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
324
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
167